
Medicines, Long-term Care and Home Care
The Impact of Keeping Them Out of the Medicare Model
Fourth Annual Roundtable Discussion of the McGill University Health Centre’s Institute for Strategic Analysis and Innovation
October 20, 2011, 10am to 12pm
Employees’ Lounge/Nurses’ Lounge (Room H4.56)
MUHC (Royal Victoria Hospital) 687 Pine Avenue W., Montreal
| The Round Table Part 1 (video) | Conference Chairs: | |
The Honourable Arthur T. Porter, P.C. MD |
Dr. Philippe Couillard |
- What programmes have evolved in different provinces/territories for the provision of medicines, long-term care and home care and how do these affect health-system effectiveness and equity of health care?
- What would be the potential advantages and disadvantages of bringing these services under the Canada Health Act (CHA) umbrella?
- What lessons can we draw from these programmes for services currently covered by the CHA?
| The Round Table - Part 2 (video) | PARTICIPANTS: Dr. Anita Brown-Johnson, Director of Transition Care, Director, Transition Care Services; |
| Questions and Discussion (video) | Mr. Michel Clair, President, Sedna Health Group Mr. Alain Robillard, Partner, Mercer Mr. Joe Sardi, Consultant, GE Healthcare Mr. Barry Stein, President, Colorectal Cancer Association of Canada Ms. Helen Stevenson, President and CEO, Reformulary Group |
About the McGill University Health Centre’s Institute for Strategic Analysis and Innovation:
The McGill University Health Centre (MUHC) is strongly committed to a tradition of adopting, developing and deploying pioneering health care innovations to improve the quality of care and outcomes for the patients it serves. Recognizing that both the external policy environment and its own mandate were undergoing significant changes, the MUHC saw the need for better linkage between health care policy development and the hospital reality. In 2007, the MUHC created the Institute for Strategic Analysis and Innovation (ISAI). The Institute’s objective is to enable the MUHC as a tertiary care teaching hospital to contribute to the ongoing development of health care policy and promote innovations that improve patient outcomes.








